Match tier Institution-verified
Presence Current · Arkansas
Last published 2026
Sources Institutional record
Refreshed 2026-10-08

Marjan Boerma

Sourced from institutional research profiles (UAMS TRI or ARA).

Federal Grant PI High Impact

Professor

Also affiliated: American Heart Association (2006); National Institutes of Health (2007); Loma Linda University (2015); University of Arkansas Medical Center (2006–2022); Leiden University Medical Center (2002–2005); Moffitt Cancer Center (2012); Central Arkansas Veterans Healthcare System (2005–2015); Arkansas Biosciences Institute (2006); John L. McClellan Memorial Veterans Hospital (2009); Charité - Universitätsmedizin Berlin (2012)

37 h-index 225 pubs 5,353 cited

  • Animals
  • Male
  • Mice
  • Humans
  • Mice, Inbred C57BL
  • Rats
  • Heart
  • Radiation Injuries
  • Female
  • Oxidative Stress
  • Cosmic Radiation
  • Dose-Response Relationship, Radiation
  • Rats, Sprague-Dawley
  • Radiation, Ionizing
  • Myocardium

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Marjan Boerma's research focuses on elucidating the biological mechanisms by which cancer therapies cause cardiovascular injury and identifying potential countermeasures. This work utilizes pre-clinical research models to investigate the cardiac side effects of radiation therapy, both alone and in combination with chemotherapeutic agents. Assessments include cardiac function, tissue structure, and molecular alterations in response to these treatments.

Boerma has received significant federal funding for this research, totaling $3,602,703 across four awards from the NIH. These grants support projects such as the development of minimally invasive biomarker assays for delayed radiation injury and the establishment of a center for studies on host response to cancer therapy. Collaborations within the University of Arkansas for Medical Sciences include work with Vijayalakshmi Sridharan, Igor Koturbash, Ashley Nemec-Bakk, and Rupak Pathak, evidenced by multiple shared publications.

With a career marked by extensive scholarship, Boerma has authored 224 publications with over 5,333 citations and maintains an h-index of 37. This productivity has led to recognition as a highly cited, high-impact researcher. Boerma leads an active research group and maintains a lab website, indicating ongoing research endeavors.

Metrics

  • h-index: 37
  • Publications: 225
  • Citations: 5,353

Positions

  • Professor 2021–present
    University of Arkansas for Medical Sciences Pharmaceutical Sciences Institutional directory
  • Associate Professor 2012–2021
    University of Arkansas for Medical Sciences Pharmaceutical Sciences ORCID
  • Assistant Professor 2006–2012
    University of Arkansas for Medical Sciences Pharmaceutical Sciences ORCID
  • Postdoctoral Fellow 2004–2006
    University of Arkansas for Medical Sciences Surgery ORCID

Selected Publications

  • Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling (2026)
    International Journal of Molecular Sciences 1 citation DOI OpenAlex
  • Dataset for: Multi-organ acute and delayed effects following exposure to neutron radiation (2026)
  • Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025)
    Frontiers in Immunology 1 citation DOI OpenAlex
  • Exposure to a Single Dose of Space-Relevant Proton Radiation Alters the Intestinal One-Carbon Metabolism Pathway and Microbiome in Mice (2025)
    Radiation Research 1 citation DOI OpenAlex
  • Adverse Outcome Pathways Applied to Space Radiation Research (2025)
    Environmental and Molecular Mutagenesis 5 citations DOI OpenAlex
  • Sex-specific immune alterations in mice following long-term simulated microgravity and chronic irradiation (2025)
    npj Microgravity 1 citation DOI OpenAlex
  • A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity (2025)
    Metabolomics 13 citations DOI OpenAlex
  • Long-term effects of combined exposures to simulated microgravity and galactic cosmic radiation on the mouse lung: sex-specific epigenetic reprogramming (2025)
    Radiation and Environmental Biophysics 3 citations DOI OpenAlex
  • Bridging Earth and Space: A Flexible and Resilient Federated Learning Framework Deployed on the International Space Station (2025)
    bioRxiv (Cold Spring Harbor Laboratory) 1 citation DOI OpenAlex
  • Distinct Urinary Metabolite Signatures Mirror In Vivo Oxidative Stress-Related Radiation Responses in Mice (2024)
    Antioxidants 5 citations DOI OpenAlex
  • Sex-specific effects on the heart from combined exposure to simulated galactic cosmic radiation and hindlimb unloading (2024)
    Life Sciences in Space Research 3 citations DOI OpenAlex
  • AOP report: Development of an adverse outcome pathway for deposition of energy leading to abnormal vascular remodeling (2024)
    Environmental and Molecular Mutagenesis 10 citations DOI OpenAlex
  • Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease (2024)
    JCI Insight 2 citations DOI OpenAlex
  • Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury (2024)
    Journal of Neuroinflammation 17 citations DOI OpenAlex
  • Effects of confounding and effect-modifying lifestyle, environmental and medical factors on risk of radiation-associated cardiovascular disease (2024)
    BMC Public Health 7 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 4 $3,602,703 total

NIH Contact PI Aug 2025 - May 2030

COBRE Phase III

National Institute of General Medical Sciences $1,147,500 P30
NIH Contact PI Feb 2020 - Jan 2026

Development of a minimally invasive biomarker assay to detect delayed radiation injury

NIH Office of the Director $395,650 U01
NIH Contact PI Jun 2017 - Nov 2022

The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction

NIH Office of the Director $588,106 U01
NIH Contact PI Jun 2015 - May 2026

Center for Studies of Host Response to Cancer Therapy

National Institute of General Medical Sciences $1,471,447 P20

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • ABI C. OBrien NIH COBRE FY26 Y4 State of Arkansas
  • Effects of Chronic and Single-dose Charged Particle Exposure on Cardiac Function and Structure in Multiple Animal Models National Aeronautics & Space Administration
  • Platelets in radiation-induced immune dysregulation NIH/Nat. Inst. of Allergy & Infectious Diseases
  • Impact of hemodynamics on efferocytosis in endothelial cells NIH/Nat. Heart, Lung & Blood Institute
  • Metabolomics Based Prediction of Delayed Effects of Acute Radiation Exposure NIH/Nat. Inst. of Allergy & Infectious Diseases via Nelson Scientific Labs, LLC
  • Tocotrienol as a countermeasure against high-energy charged particle-induced carcinogenesis, cardiovascular disease, and central nervous system effects- Resubmission National Aeronautics & Space Administration
  • Advanced development of multi-omics based assays to predict late radiation organinjuries - the DEARE-Watch project NIH
  • Team Leader for the Radiation Effects Team National Space Biomedical Research Institute via Baylor College of Medicine

Collaboration Network

554 Collaborators 226 Institutions 22 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics